Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging Study of Fluticasone Furoate in Children with Asthma
NCT01563029Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2012
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands
- Countries
- 15
01
Overview
A Phase 2 trial of fluticasone in asthma, sponsored by GSK. Started Mar 2012; status: completed.
02
Drugs
fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01563029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01563029.